Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels
ConclusionsWe concluded that there was no significant difference between PVT patients presenting with subtherapeutic and high INR levels who received thrombolytic treatments regarding both minor and major bleeding complications as well as response to thrombolysis.
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Khadijeh Farzaneh,
Seyedeh Hamideh Mortazavi,
Alireza Oraii,
Kyomars Abbasi,
Abbas Salehi Omran,
Seyed Hossein Ahmadi Tafti,
Ali Bozorgi,
Ali Kazemi Saeed,
Mojtaba Salarifar,
Saeed Sadeghian Tags: ORIGINAL ARTICLE Source Type: research
More News: Bleeding | Cardiology | Cardiovascular & Thoracic Surgery | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Hemorrhagic Stroke | Stroke | Study | Thrombolytic Therapy | Thrombosis